<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">
 <list list-type="bullet">
  <list-item>
   <p id="Par8">Optimal viral subtypes as well, as the impact of preexisting anti-viral immunity may still be determined.</p>
  </list-item>
  <list-item>
   <p id="Par9">Combination with other therapeutic modalities should be explored.</p>
  </list-item>
  <list-item>
   <p id="Par10">Oncolytic effects on clinical outcome needs to be proven in prospective randomized clinical trials.</p>
  </list-item>
 </list>
</p>
